Complete paraplegia after Nelarabine treatment in a T‐cell acute lymphoblastic leukemia adult patient
- 28 April 2010
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 85 (8) , 608
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)Blood, 2009
- FDA Drug Approval Summary: Nelarabine (Arranon®) for the Treatment of T-Cell Lymphoblastic Leukemia/LymphomaThe Oncologist, 2008